OmniAb, Inc. (NASDAQ:OABI) Insider Sells $82,584.36 in Stock

OmniAb, Inc. (NASDAQ:OABI) insider Charles S. Berkman sold 25,489 shares of OmniAb stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $3.24, for a total value of $82,584.36. Following the completion of the sale, the insider now directly owns 343,190 shares of the company’s stock, valued at $1,111,935.60. The trade was a 6.91 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

OmniAb Price Performance

OABI opened at $3.20 on Friday. The business has a fifty day moving average price of $3.64 and a 200 day moving average price of $4.05. The stock has a market capitalization of $451.90 million, a price-to-earnings ratio of -5.16 and a beta of -0.10. OmniAb, Inc. has a 12 month low of $3.11 and a 12 month high of $6.55.

Analysts Set New Price Targets

Several research analysts recently commented on the company. HC Wainwright reissued a “buy” rating and set a $11.00 target price on shares of OmniAb in a research note on Thursday, November 14th. Benchmark reissued a “buy” rating and set a $8.00 target price on shares of OmniAb in a research note on Thursday, November 14th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in OABI. CWC Advisors LLC. acquired a new position in shares of OmniAb during the 3rd quarter worth about $54,000. Walleye Capital LLC acquired a new position in shares of OmniAb during the 3rd quarter worth about $61,000. Intech Investment Management LLC acquired a new position in shares of OmniAb during the 3rd quarter worth about $70,000. China Universal Asset Management Co. Ltd. boosted its position in shares of OmniAb by 64.5% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 22,727 shares of the company’s stock worth $96,000 after acquiring an additional 8,909 shares in the last quarter. Finally, Palumbo Wealth Management LLC boosted its position in shares of OmniAb by 12.5% during the 3rd quarter. Palumbo Wealth Management LLC now owns 24,640 shares of the company’s stock worth $104,000 after acquiring an additional 2,744 shares in the last quarter. 72.08% of the stock is owned by institutional investors and hedge funds.

About OmniAb

OmniAb, Inc, a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts.